维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

15篇 您的检索式：作者名="John Aponte"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Malaria: Global progress 2000-2015 and future challenges显示文摘Background:2015 was the target year for malaria goals set by the World Health Assembly and other international institutions to reduce malaria incidence and mortality.A review of progress indicates that malaria programme financing and coverage have been transformed since the beginning of the millennium,and have contributed to substantial reductions in the burden of disease.Findings:Investments in malaria programmes increased by more than 2.5 times between 2005 and 2014 from US$960 million to US$2.5 billion,allowing an expansion in malaria prevention,diagnostic testing and treatment programmes.In 2015 more than half of the population of sub-Saharan Africa slept under insecticide-treated mosquito nets,compared to just 2%in 2000.Increased availability of rapid diagnostic tests and antimalarial medicines has allowed many more people to access timely and appropriate treatment.Malaria incidence rates have decreased by 37%globally and mortality rates by 60%since 2000.It is estimated that 70%of the reductions in numbers of cases in sub-Saharan Africa can be attributed to malaria interventions.Conclusions:Reductions in malaria incidence and mortality rates have been made in every WHO region and almost every country.However,decreases in malaria case incidence and mortality rates were slowest in countries that had the largest numbers of malaria cases and deaths in 2000;reductions in incidence need to be greatly accelerated in these countries to achieve future malaria targets.Progress is made challenging because malaria is concentrated in countries and areas with the least resourced health systems and the least ability to pay for system improvements.Malaria interventions are nevertheless highly cost-effective and have not only led to significant reductions in the incidence of the disease but are estimated to have saved about US$900 million in malaria case management costs to public providers in sub-Saharan Africa between 2000 and 2014.Investments in malaria programmes can not only reduce malaria morbidity and mortality,thereby contributing to the health targets of the Sustainable Development Goals,but they can also transform the well-being and livelihood of some of the poorest communities across the globe.	Richard E.Cibulskis Pedro Alonso John Aponte Maru Aregawi Amy Barrette Laurent Bergeron Cristin A.Fergus Tessa Knox Michael Lynch Edith Patouillard Silvia Schwarte Saira Stewart Ryan Williams	2016	Infectious Diseases of Poverty2016，5，1：	4
	2	Prognostic Significance of Uric Acid Serum Concentration in Patients With Acute Ischemic Stroke显示文摘	ángel Chamorro Victor Obach álvaro Cervera Marian Revilla Ramón Deulofeu John H. Aponte	2002	Stroke: Journal of the American Heart Association2002，，：	1
	3	Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial显示文摘	Josep M Llovet Maria Isabel Real Xavier Monta?a Ramon Planas Susana Coll John Aponte Carmen Ayuso Margarita Sala Jordi Muchart Ricard Solà Joan Rodés Jordi Bruix	2002	The Lancet2002，，9319：	1
	4	Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial显示文摘	Josep M Llovet Maria Isabel Real Xavier Monta?a Ramon Planas Susana Coll John Aponte Carmen Ayuso Margarita Sala Jordi Muchart Ricard Solà Joan Rodés Jordi Bruix	2002	The Lancet2002，，9319：	1
	5	Unfractionated heparin is associated with a lower rise of serum vascular cell adhesion molecule-1 in acute ischemic stroke patients显示文摘	ángel Chamorro álvaro Cervera José Castillo Antonio Dávalos John J Aponte Ana M Planas	2002	Neuroscience Letters2002，，3：	1
	6	Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis显示文摘	Tilman M Bauer Bernhard Steinbrückner Folke E Brinkmann Anette K Ditzen Henning Schwacha John J Aponte Klaus Pelz Manfred Kist Hubert E Blum	2001	The American Journal of Gastroenterology2001，，10：	1
	7	Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial显示文摘	Josep M Llovet Maria Isabel Real Xavier Monta?a Ramon Planas Susana Coll John Aponte Carmen Ayuso Margarita Sala Jordi Muchart Ricard Solà Joan Rodés Jordi Bruix	2002	The Lancet2002，，9319：	1
	8	Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model显示文摘	Xavier Forns Sergi Ampurdanès Josep M. Llovet John Aponte Lloren? Quintó Eva Mart??nez-Bauer Miquel Bruguera Jose Maria Sánchez-Tapias Juan Rodés	2002	Hepatology2002，，4：	1
	9	Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial显示文摘	Josep M Llovet Maria Isabel Real Xavier Monta?a Ramon Planas Susana Coll John Aponte Carmen Ayuso Margarita Sala Jordi Muchart Ricard Solà Joan Rodés Jordi Bruix	2002	The Lancet2002，，9319：	1
	10	Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia显示文摘	Tilman M Bauer Henning Schwacha Bernhard Steinbrückner Folke E Brinkmann Anette K Ditzen John J Aponte Klaus Pelz Dieter Berger Manfred Kist Hubert E Blum	2002	The American Journal of Gastroenterology2002，，：	1
	11	Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia显示文摘	Tilman M Bauer Henning Schwacha Bernhard Steinbrückner Folke E Brinkmann Anette K Ditzen John J Aponte Klaus Pelz Dieter Berger Manfred Kist Hubert E Blum	2002	The American Journal of Gastroenterology2002，，9：	1
	12	Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants显示文摘	Clara Menendez Elizeus Kahigwa Rosmarie Hirt Penelope Vounatsou John J Aponte Fidel Font Camilo J Acosta David M Schellenberg Claudia M Galindo John Kimario Honorathy Urassa Bernard Brabin Tom A Smith Andrew Y Kitua Marcel Tanner Pedro L Alonso	1997	The Lancet1997，，9081：	1
	13	Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial显示文摘	Josep M Llovet Maria Isabel Real Xavier Monta?a Ramon Planas Susana Coll John Aponte Carmen Ayuso Margarita Sala Jordi Muchart Ricard Solà Joan Rodés Jordi Bruix	2002	The Lancet2002，，9319：	1
	14	Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial显示文摘	Josep M Llovet Maria Isabel Real Xavier Monta?a Ramon Planas Susana Coll John Aponte Carmen Ayuso Margarita Sala Jordi Muchart Ricard Solà Joan Rodés Jordi Bruix	2002	The Lancet2002，，9319：	1
	15	Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial显示文摘	Josep M Llovet Maria Isabel Real Xavier Monta?a Ramon Planas Susana Coll John Aponte Carmen Ayuso Margarita Sala Jordi Muchart Ricard Solà Joan Rodés Jordi Bruix	2002	The Lancet2002，，9319：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费